Bendamustine in the treatment of multiple myeloma:: Results and future perspectives

被引：18
|
作者：
Pönisch, W
Niederwieser, D
机构：
[1] Univ Leipzig, Div Hematol & Oncol, D-4103 Leipzig, Germany
[2] Univ Leipzig, E German Study Grp Hematol & Oncol, D-4103 Leipzig, Germany
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 04期
关键词：
D O I：
10.1016/S0093-7754(02)90011-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：23 / 26
页数：4
相关论文
共 50 条
  • [21] State of the art therapy in multiple myeloma and future perspectives
    Denz, Ulrich
    Haas, Peter S.
    Waesch, Ralph
    Einsele, Hermann
    Engelhardt, Monika
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (11) : 1591 - 1600
  • [22] Lenalidomide in Multiple Myeloma: Review of Resistance Mechanisms, Current Treatment Strategies and Future Perspectives
    Kulig, Piotr
    Milczarek, Slawomir
    Bakinowska, Estera
    Szalewska, Laura
    Baumert, Bartlomiej
    Machalinski, Boguslaw
    CANCERS, 2023, 15 (03)
  • [23] Bendamustine in patients with relapsed or refractory multiple myeloma
    M Michael
    I Bruns
    E Bölke
    F Zohren
    A Czibere
    N N Safaian
    F Neumann
    R Haas
    G Kobbe
    R Fenk
    European Journal of Medical Research, 15
  • [24] MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA WITH BENDAMUSTINE
    Cerchione, C.
    Madonna, E.
    Pareto, A. E.
    Marano, L.
    Pugliese, N.
    Peluso, I.
    Seneca, E.
    Cerciello, G.
    Avilia, S.
    Basile, S.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2014, 99 : 650 - 650
  • [25] Bortezomib in combination with bendamustine and preduisone in the treatment of patients with refractory/relapsed multiple myeloma
    Poenisch, Wolfram
    Bourgeois, Malvina
    Wang, Song-Yau
    Heyn, Simone F.
    Jaekel, Nadja
    Braunert, Leanthe
    Rohrberg, Robert
    Hurtz, Hans Juergen
    Hoffmann, Franz Albert
    Schwarzer, Andreas
    Becker, Cornelia
    Al Ali, Haifa
    Niederwieser, Dietger W.
    BLOOD, 2007, 110 (11) : 799A - 800A
  • [26] Indolent Lymphomas - Results and Perspectives of Bendamustine
    Ortner, Petra
    ONKOLOGIE, 2011, 34 (8-9): : 478 - 478
  • [27] Bendamustine and prednisone in combination with Bortezomib in the treatment of patients with relapsed/refractory multiple myeloma
    Poenisch, W.
    Bourgeois, M.
    Heyn, S.
    Wagner, I
    Jaekel, N.
    Rohrberg, R.
    Hurtz, H. -J.
    Schmalfeld, M.
    Assmann, M.
    Edelmann, T.
    Mohren, M.
    Hoffmann, F. A.
    Schwarzer, A.
    Hensel, G.
    Loeschke, K.
    Becker, C.
    Krahl, R.
    Al-Ali, H. K.
    Niederwieser, D.
    ONKOLOGIE, 2012, 35 : 144 - 144
  • [28] Bortezomib in combination with bendamustine and prednisone in the treatment of patients with refractory/relapsed multiple myeloma
    Poenisch, W.
    Bourgeois, M.
    Wang, S. Y.
    Heyn, S.
    Jaekel, N.
    Al Ali, H.
    Niederwieser, D.
    ONKOLOGIE, 2008, 31 : 136 - 136
  • [29] BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Michael, M.
    Bruns, I.
    Boelke, E.
    Zohren, F.
    Czibere, A.
    Safaian, N. N.
    Ncumann, F.
    Haas, R.
    Kobbe, G.
    Fenk, R.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (01) : 13 - 19
  • [30] Patient Perspectives of Thromboprophylaxis in Multiple Myeloma: Results from the Thromboprophylaxis in Multiple Myeloma (TiMM) study
    Sayar, Z.
    Czuprynska, J.
    Patel, J. P.
    Benjamin, R.
    Roberts, L. N.
    Patel, R. K.
    Cornelius, V.
    Arya, R.
    THROMBOSIS RESEARCH, 2018, 164 : S189 - S190
12345